endocrinology
Bone health

Xgeva contraindicated for patients with dental complications

Denosumab (Xgeva) should not be prescribed to patients with unhealed lesions from dental or oral surgery, the TGA has confirmed in its latest Medicines Safety Update. Osteonecrosis of the jaw (ONJ) is already a known adverse event highlighted in the PI documents of both brands marketed in Australia – Prolia and Xgeva. However the TGA ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic